Summary
The countries of Western Europe represent a total market of over 365 million people and a combined GDP of US$14.4 trillion in 2007. The 11 main Western European markets for pharmaceuticals are wealthy and mature. Is there any point in manufacturers trying to break into markets they are not already servicing, and, if yes, where? If they are already operating in the region, what are the prospects for growth and what operating environment will they face in the future? Valuable markets... News stories chronicle the pressures and problems facing governments trying to expand or maintain health provision in a cost-constrained world. But one fact remains. The countries covered by this report represent a total pharmaceutical market value of US$204.7 billion. We forecast this figure will grow by US$40.1 billion over the next five years to US$245.3 billion. ...with cost pressures All health funders are experiencing difficulties in meeting the demands on modern health systems. Pressures arise from many quarters including: - The cost of current branded medicines which is leading to accelerated growth in generic usage in key markets such as Spain and France
- The often high cost of new therapies which provide marginal therapeutic benefit
- An ageing population needing longer and more intensive medical treatments
- Unplanned population increase due to immigration and an influx of migrant workers
These reports analyse the issues The Outlook for Pharmaceutical Markets in Western Europe to 2012 is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report sent annually. There are over 65 markets covered in the worldwide series. 11 Key Markets Covered - Austria
- Belgium
- France
- Germany
- Ireland
- Italy
- Netherlands
- Portugal
- Spain
- Switzerland
- United Kingdom
|
